516 related articles for article (PubMed ID: 19621141)
21. A prospective study of admissions for febrile neutropenia in secondary paediatric units in South East England.
Duncan C; Chisholm JC; Freeman S; Riley U; Sharland M; Pritchard-Jones K
Pediatr Blood Cancer; 2007 Oct; 49(5):678-81. PubMed ID: 17066460
[TBL] [Abstract][Full Text] [Related]
22. [High risk febrile neutropenia in acute leukemia. The experience of a public hospital. National Program of Antineoplastic Drugs in Adult, Hospital del Salvador, 1991-2001].
Puga B; Puga I; Cabrera ME; Undurraga MS; Guerra C; Urrejola G; Toro P
Rev Med Chil; 2003 Sep; 131(9):1023-30. PubMed ID: 14635589
[TBL] [Abstract][Full Text] [Related]
23. Bloodstream infections in cancer patients with febrile neutropenia.
Feld R
Int J Antimicrob Agents; 2008 Nov; 32 Suppl 1():S30-3. PubMed ID: 18778919
[TBL] [Abstract][Full Text] [Related]
24. Microbiology and mortality of pediatric febrile neutropenia in El Salvador.
Gupta S; Bonilla M; Gamero M; Fuentes SL; Caniza M; Sung L
J Pediatr Hematol Oncol; 2011 May; 33(4):276-80. PubMed ID: 21516023
[TBL] [Abstract][Full Text] [Related]
25. Surveillance study of bacteraemic episodes in febrile neutropenic children.
Ariffin H; Navaratnam P; Lin HP
Int J Clin Pract; 2002 May; 56(4):237-40. PubMed ID: 12074201
[TBL] [Abstract][Full Text] [Related]
26. Significance of C-reactive protein during febrile neutropenia in pediatric malignancies.
Avabratha KS; Rau AT; Venkataravanamma P; Rau A
Indian Pediatr; 2009 Sep; 46(9):797-9. PubMed ID: 19430077
[TBL] [Abstract][Full Text] [Related]
27. [Invasive fungal infections in children with cancer, neutropenia and fever, in Chile].
Lucero Y; Brücher R; Alvarez AM; Becker A; Cofré J; Enríquez N; Payá E; Salgado C; Santolaya ME; Tordecilla J; Varas M; Villarroel M; Viviani T; Zubieta M; O'Ryan M
Rev Med Chil; 2002 Oct; 130(10):1139-46. PubMed ID: 12491831
[TBL] [Abstract][Full Text] [Related]
28. Cefepime and amikacin as empirical therapy in patients with febrile neutropaenia: a single-centre phase II prospective survey.
Mebis J; Vandeplassche S; Goossens H; Berneman ZN
Acta Clin Belg; 2009; 64(1):35-41. PubMed ID: 19317239
[TBL] [Abstract][Full Text] [Related]
29. Treatment of febrile neutropenic patients with cancer who require hospitalization: a prospective randomized study comparing imipenem and cefepime.
Raad II; Escalante C; Hachem RY; Hanna HA; Husni R; Afif C; Boktour MR; Whimbey EE; Kontoyiannis D; Jacobson K; Kantarjian H; Levett LM; Rolston KV
Cancer; 2003 Sep; 98(5):1039-47. PubMed ID: 12942573
[TBL] [Abstract][Full Text] [Related]
30. A multi-centre prospective study of febrile neutropenia in Norway: microbiological findings and antimicrobial susceptibility.
Sigurdardottir K; Digranes A; Harthug S; Nesthus I; Tangen JM; Dybdahl B; Meyer P; Hopen G; Løkeland T; Grøttum K; Vie W; Langeland N
Scand J Infect Dis; 2005; 37(6-7):455-64. PubMed ID: 16012006
[TBL] [Abstract][Full Text] [Related]
31. Management of the febrile neutropenic patient.
Picazo JJ;
Int J Antimicrob Agents; 2005 Dec; 26 Suppl 2():S120-2; discussion S133-40. PubMed ID: 16243492
[TBL] [Abstract][Full Text] [Related]
32. Febrile neutropenia in paediatric peripheral blood stem cell transplantation, in -vitro sensitivity data and clinical response to empirical antibiotic therapy.
Ansari SH; Nasim S; Ahmed A; Irfan M; Ishaque A; Farzana T; Panjwani VK; Taj M; Shamsi TS
J Coll Physicians Surg Pak; 2006 Nov; 16(11):704-8. PubMed ID: 17052420
[TBL] [Abstract][Full Text] [Related]
33. High-risk febrile neutropenia in Auckland 2003-2004: the influence of the microbiology laboratory on patient treatment and the use of pathogen-specific therapy.
Ritchie S; Palmer S; Ellis-Pegler R
Intern Med J; 2007 Jan; 37(1):26-31. PubMed ID: 17199841
[TBL] [Abstract][Full Text] [Related]
34. Clinical and microbiologic determinants of serious bloodstream infections in Egyptian pediatric cancer patients: a one-year study.
El-Mahallawy H; Sidhom I; El-Din NH; Zamzam M; El-Lamie MM
Int J Infect Dis; 2005 Jan; 9(1):43-51. PubMed ID: 15603994
[TBL] [Abstract][Full Text] [Related]
35. Applying the Multinational Association for Supportive Care in Cancer risk scoring in predicting outcome of febrile neutropenia patients in a cohort of patients.
Baskaran ND; Gan GG; Adeeba K
Ann Hematol; 2008 Jul; 87(7):563-9. PubMed ID: 18437382
[TBL] [Abstract][Full Text] [Related]
36. Infections in acute myeloid leukemia. Study of 184 febrile episodes.
Kumar L; Kochupillai V; Bhujwala RA
J Assoc Physicians India; 1992 Jan; 40(1):18-20. PubMed ID: 1634456
[TBL] [Abstract][Full Text] [Related]
37. Bloodstream infections in patients with solid tumors: associated factors, microbial spectrum and outcome.
Anatoliotaki M; Valatas V; Mantadakis E; Apostolakou H; Mavroudis D; Georgoulias V; Rolston KV; Kontoyiannis DP; Galanakis E; Samonis G
Infection; 2004 Apr; 32(2):65-71. PubMed ID: 15057569
[TBL] [Abstract][Full Text] [Related]
38. Febrile neutropenia in children with cancer: a retrospective Norwegian multicentre study of clinical and microbiological outcome.
Stabell N; Nordal E; Stensvold E; Gammelsrud KW; Lund B; Taxt A; Buhring F; Greve-Isdahl M; Fornebo HP; Simonsen GS; Klingenberg C
Scand J Infect Dis; 2008; 40(4):301-7. PubMed ID: 17918015
[TBL] [Abstract][Full Text] [Related]
39. Bacterial infections in low-risk, febrile neutropenic patients.
Kamana M; Escalante C; Mullen CA; Frisbee-Hume S; Rolston KV
Cancer; 2005 Jul; 104(2):422-6. PubMed ID: 15937905
[TBL] [Abstract][Full Text] [Related]
40. Febrile neutropenia in allogeneic and autologous peripheral blood stem cell transplantation and conventional chemotherapy for malignancies.
Celebi H; Akan H; Akçağlayan E; Ustün C; Arat M
Bone Marrow Transplant; 2000 Jul; 26(2):211-4. PubMed ID: 10918433
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
